A review of safety, efficacy, and utilization of erythropoietin, darbepoetin, and peginesatide for patients with cancer or chronic kidney disease: a report from the Southern Network on Adverse Reactions (SONAR).

Bennett, Charles L; Spiegel, David M; Macdougall, Iain C; Norris, LeAnn; Qureshi, Zaina P; Sartor, Oliver; Lai, Stephen Y; Tallman, Martin S; Raisch, Dennis W; Smith, Sheila Weiss; Silver, Samuel; Murday, Alanna S; Armitage, James O; Goldsmith, David

Bennett, Charles L; Spiegel, David M; Macdougall, Iain C; Norris, LeAnn; Qureshi, Zaina P; Sartor, Oliver; Lai, Stephen Y; Tallman, Martin S; Raisch, Dennis W; Smith, Sheila Weiss; Silver, Samuel; Murday, Alanna S; Armitage, James O; Goldsmith, David.

Afiliación

Bennett CL; The Southern Network on Adverse Reactions project, the South Carolina Center of Economic Excellence for Medication Safety, the South Carolina College of Pharmacy, Columbia, USA. bennettc@sccp.sc.edu

Semin Thromb Hemost ; 38(8): 783-96, 2012 Nov.

Article en En | MEDLINE | ID: mdl-23111861

Asunto(s)

Eritropoyetina/análogos & derivados; Eritropoyetina/uso terapéutico; Neoplasias/tratamiento farmacológico; Péptidos/uso terapéutico; Insuficiencia Renal Crónica/tratamiento farmacológico; Darbepoetina alfa; Eritropoyetina/efectos adversos; Humanos; Péptidos/efectos adversos

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Péptidos / Eritropoyetina / Insuficiencia Renal Crónica / Neoplasias Tipo de estudio: Guideline / Systematic_reviews Límite: Humans Idioma: En Revista: Semin Thromb Hemost Año: 2012 Tipo del documento: Article País de afiliación: Estados Unidos

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google